Lam, M. G. E. H., Bosma, T. B., van Rijk, P. P., & Zonnenberg, B. A. (2009). (188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: A phase I safety and toxicity study. Springer-Verlag.
Stile di citazione ChicagoLam, Marnix G. E. H., Tjitske B. Bosma, Peter P. van Rijk, e Bernard A. Zonnenberg. (188)Re-HEDP Combined With Capecitabine in Hormone-refractory Prostate Cancer Patients With Bone Metastases: A Phase I Safety and Toxicity Study. Springer-Verlag, 2009.
Citazione MLALam, Marnix G. E. H., Tjitske B. Bosma, Peter P. van Rijk, e Bernard A. Zonnenberg. (188)Re-HEDP Combined With Capecitabine in Hormone-refractory Prostate Cancer Patients With Bone Metastases: A Phase I Safety and Toxicity Study. Springer-Verlag, 2009.